Economics of herd rebuilding depend on cull rate, study finds

Nov 10, 2022

The study drew information from 17 farms registered with the council’s cow-calf production network from Western Canada and northern Ontario, said Brenna Grant, executive director of CanFax. It then modelled the farms’ recovery, based on a projected cull level (ranging from no extra culls to a 25, 50 or 75 per cent herd loss) and recovery strategy (purchased replacement stock versus replacement heifers).

“The overall objective that we wanted to answer with this study was: How do you minimize the equity drain on the operation?” Grant said.

A farm’s circumstances are rarely cut and dried, she said. Choices might hinge on availability of local feed or how strongly the producer wants to preserve herd genetics or level of concern about biosecurity when bringing in new stock. Cash flow also affects a producer’s ability to buy replacements.

Click here to see more...

Video: How Aurora Pharmaceutical Became a Leader in Animal Health

Dr. Michael Strobel, Founder and CEO of Aurora Pharmaceutical, discusses the company's remarkable journey from a veterinarian-led startup to a leading developer and manufacturer of animal health solutions.

In this exclusive interview, Dr. Strobel shares how Aurora Pharmaceutical was built around a simple but powerful mission: putting customers, producers, veterinarians, pet owners, and patients first. Learn how the company has grown by focusing on high-quality, science-backed, and cost-effective solutions for livestock, companion animals, and human health markets.

Discover how Aurora's commitment to innovation, affordability, and customer service continues to drive its expansion across swine, cattle, poultry, equine, companion animal, and human health sectors. Dr. Strobel also discusses the importance of understanding real-world challenges facing producers and veterinarians and how Aurora develops practical solutions that improve animal health while supporting producer profitability. Aurora's veterinarian-founded approach, commitment to American manufacturing, and focus on delivering value have helped establish the company as a trusted partner throughout the animal health industry.